4DMedical’s XV Technology is transforming pharma and medtech productivity
Minimising risk for globally prominent B2B customers – improving measurement of drug efficacy, and prioritising pipeline assets and the most promising technologies with business confidence gained from clearer insights.
Commercial contract signed with Novartis
4DMedical announced the signing of a commercial contract with Novartis.
Under the terms of the agreement, XV Ventilation Reports will be provided to Novartis on a commercial basis…
The XV Technology Lung Ventilation Analysis Software provides a non-invasive way of understanding regional lung function during active breathing. It enables highly-detailed colour-coded maps and other health metrics for clearer insights into lung health.